Royalty Pharma plc
- Stock
- Ticker RPRX
- ISIN GB00BMVP7Y09
- Nasdaq
- US listing in dollars
Performance, volatility and drawdowns of Royalty Pharma plc since 06/2020, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $19,521. Global equities (VT): $14,653.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −49.7% in 12/2024, measured from the peak in 01/2021. It took 61 months to get back to the old peak.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 594 | 568 | 579 | 609 | 622 | 631 | 674 | 690 |
| Operating income | 362 | 534 | 210 | 427 | 388 | 563 | 133 | 411 |
| EBITDA | 362 | 534 | 211 | 428 | 390 | 564 | 134 | 412 |
| Net income | 208 | 239 | 32 | 284 | 215 | 295 | 18 | 145 |
| Earnings per share | 0.47 | 0.55 | 0.07 | 0.66 | 0.50 | 0.67 | 0.04 | 0.32 |
| Balance sheet | ||||||||
| Total assets | 18,223 | 17,608 | 18,323 | 19,347 | 19,621 | 19,815 | 19,820 | 19,461 |
| Liabilities | 7,880 | 7,820 | 8,820 | 9,726 | 9,906 | 9,879 | 10,034 | 9,666 |
| Equity | 10,342 | 9,778 | 9,494 | 9,608 | 9,715 | 9,937 | 9,786 | 9,795 |
| Cash | 929 | 1,088 | 632 | 939 | 619 | 586 | 812 | 514 |
| Long-term debt | 6,615 | 6,619 | 7,003 | 8,566 | 8,571 | 8,576 | 8,582 | 7,591 |
| Cash flow | ||||||||
| Operating cash flow | 743 | 596 | 364 | 703 | 827 | 718 | 728 | 686 |
| Free cash flow | 743 | 596 | 364 | 703 | 827 | 718 | 728 | 686 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2025 at +55.2%, weakest 2023 at −27.1%. 2 of 5 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 4 Nov 2026 | $0.32 |
| 5 Aug 2026 | $0.04 |
| 6 May 2026 | $0.67 |
| 11 Feb 2026 | $0.50 |
| 5 Nov 2025 | $0.66 |
| 6 Aug 2025 | $0.07 |
| 8 May 2025 | $0.55 |
| 12 Feb 2025 | $0.47 |
| 6 Nov 2024 | $1.21 |
| 8 Aug 2024 | $0.23 |
| 9 May 2024 | $0.01 |
| 15 Feb 2024 | $1.10 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €35bn
- Market cap in trading currency
- $38.1bn
- Enterprise value
- $46.2bn
- P/E
- 44.7
- P/S
- 14.57
- P/B
- 3.89
- EV/Sales
- 17.64
- EV/EBITDA
- 30.8
- Earnings yield
- 2.2%
- FCF yield
- 7.8%
Results (last four quarters)
- Revenue
- $2.62bn
- Gross profit
- –
- EBITDA
- $1.50bn
- Net income
- $672m
- Earnings per share
- $1.53
- Revenue per share
- $4.70
- Revenue growth
- +13.3%
- Earnings growth
- −49.1%
Profitability
- Gross margin
- –
- Operating margin
- 57.1%
- Net margin
- 25.7%
- Return on equity
- 6.9%
- Return on assets
- 3.5%
Balance sheet and cash flow
- Cash
- $545m
- Cash per share
- $0.98
- Financial debt
- $8.59bn
- Debt/equity %
- 88
- Current ratio
- 1.29
- Book value per share
- $17.59
- Operating cash flow
- $2.96bn
- Free cash flow
- $2.96bn
Dividend
- Dividend yield
- 1.69%
- Dividend (12 months)
- $1.16
- Yield (12 months)
- 1.69%
- Payout ratio
- 76%
- Ex-dividend date
- 13 Nov 2026
Shares and trading
- Shares outstanding
- 557m
- Volume
- 3.53m
- Avg. volume 3 months
- 3.18m
- Relative volume
- 1.1
Price and technicals
- Price
- $68.45
- 1 day
- +1.1%
- 52-week high
- $70.01
- 52-week low
- $38.09
- Distance to 52-week high
- −2.2%
- Distance to 52-week low
- +79.7%
- Distance to 50-day line
- +9.9%
- Distance to 200-day line
- +23.9%
- RSI (14)
- 63
- Volatility 1M
- 17.6%
Performance
- 1 week
- −1.2%
- 1 month
- +7.4%
- 3 months
- +11.6%
- 6 months
- +25.6%
- YTD
- +77.1%
- 1 year
- +77.1%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has RPRX performed since 06/2020?
$10,000 grew to $17,685 by 20 Nov 2026, which is +9.3% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is RPRX?
Volatility was 23.7% per year, measured on monthly returns. The largest decline from a peak was −49.7%, with the low in 12/2024.
How does RPRX compare with a broad equity ETF?
Over the same period Global equities (VT) returned +12.5% per year at 15.1% volatility, RPRX returned +9.3% at 23.7%. The correlation of monthly returns was 0.32; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.
Why does this page show a US listing?
The figures use the stock's listing traded in the US. On individual days its path differs slightly from the price on the home exchange.